Format

Send to

Choose Destination
Diabetes. 2014 Sep;63(9):2904-5. doi: 10.2337/db14-0829.

Is there a sweet spot for Nrf2 activation in the treatment of diabetic kidney disease?

Author information

1
Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, CA.
2
Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, CA vbhalla@stanford.edu.
PMID:
25146471
PMCID:
PMC4141365
DOI:
10.2337/db14-0829
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center